GRETCHEN CRAWFORD: Open Payments
NPI 1518510874 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,952 in 105 payments from 15 companies in 2025. Trend: 2023 $2,655 · 2024 $3,861 · 2025 $1,952
Food & beverage: $1,952
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $690 |
| Amgen Inc. | 21 | $420 |
| PFIZER INC. | 19 | $259 |
| Organon LLC | 7 | $143 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 4 | $64 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Radius Health, Inc. | 3 | $52 |
| GENZYME CORPORATION | 2 | $48 |
| Mallinckrodt Hospital Products Inc. | 1 | $33 |
Products named: RINVOQ, TAVNEOS, XELJANZ, SKYRIZI, EVENITY, HADLIMA, OTEZLA, ORENCIA.
Industry payments across AZ — which companies pay providers there.
